IL31 and atopic eczema: Skin lesions and blood IL-31 levels were significantly increased in AD patients and positively correlated with scores on a tool that assesses severity of AD (Severity SCORing Atopic Dermatitis; SCORAD), while CsA decreased blood IL-31 levels, which correlated with reduction in disease severity and the attenuation of itch [41].